Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences gets USFDA’s final nod for Famotidine Tablets

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences receives EIR from USFDA for injectables manufacturing facility at Jarod

>>

Zydus Lifesciences jumps on getting USFDA’s approval for Pemetrexed for Injection

>>

Zydus Lifesciences gets USFDA’s approval for Pemetrexed for Injection

>>

Zydus Lifesciences informs about newspaper publication

>>

Zydus Lifesciences informs about loss of share certificate

>>

Zydus Lifesciences zooms despite reporting 41% fall in Q4 consolidated net profit

>>

Zydus Lifesciences reports 41% fall in Q4 consolidated net profit

>>

Zydus Lifesciences - Quaterly Results

<< < 64 65 66 ...168 > >>